Glossary of peptide terminology (revision 2)
Old revision·13:59, 21 Jul 2024·ReaderRosalie
This is an old revision of this page, as it stood at 13:59, 21 Jul 2024, saved by ReaderRosalie with the summary expand §Analysis and documentation. It may differ substantially from the current revision, and any error it contains may since have been corrected.
| Glossary of peptide terminology | |
|---|---|
| Scope | Terms used across this wiki |
| Arrangement | By domain, then alphabetically |
| List infobox · conventions | |
This glossary defines terms used across PeptidePedia Wiki. Each entry gives a short definition and, where a full article exists, links to it. Terms are grouped by domain and ordered alphabetically within each group.[1]
Definitions here are deliberately brief. Where a term carries a distinction that matters — purity against content, sterility against endotoxin freedom, contraindication against warning — the entry states the distinction and the article develops it.[2]
Chemistry and manufacture
[edit]- Aib
- α-aminoisobutyric acid, a non-proteinogenic residue used to block DPP-4 cleavage.
- Acylation
- Attachment of a fatty acid to a peptide, usually for albumin binding.
- Crude
- The material obtained directly after cleavage, before purification. See Crude peptide.
- Deletion sequence
- A synthesis by-product missing one or more residues.
- Fmoc
- The base-labile temporary protecting group scheme dominating peptide synthesis.
- Linker
- The resin attachment defining the C-terminal functionality of the finished peptide.
- Lyophilisation
- Freeze-drying; the isolation step producing the powder in a vial. See Lyophilisation.
- SPPS
- Assembly of a peptide on an insoluble support.
- TFA salt
- The salt form in which most reverse-phase-purified peptides are isolated.[1]
References
Categories: